Celastrol acts synergistically with afatinib to suppress non‐small cell lung cancer cell proliferation by inducing paraptosis.

MLA

Dai, Chun‐Hau, et al. “Celastrol Acts Synergistically with Afatinib to Suppress Non‐small Cell Lung Cancer Cell Proliferation by Inducing Paraptosis.” Journal of Cellular Physiology, vol. 236, no. 6, June 2021, pp. 4538–54. EBSCOhost, https://doi.org/10.1002/jcp.30172.

APA

Dai, C., Zhu, L., Wang, Y., Tang, X., Du, Y., Chen, Y., & Li, J. (2021). Celastrol acts synergistically with afatinib to suppress non‐small cell lung cancer cell proliferation by inducing paraptosis. Journal of Cellular Physiology, 236(6), 4538–4554. https://doi.org/10.1002/jcp.30172

Chicago

Dai, Chun‐Hau, Li‐Rong Zhu, Yi Wang, Xing‐Ping Tang, Yong‐Jie Du, Yong‐Chang Chen, and Jian Li. 2021. “Celastrol Acts Synergistically with Afatinib to Suppress Non‐small Cell Lung Cancer Cell Proliferation by Inducing Paraptosis.” Journal of Cellular Physiology 236 (6): 4538–54. doi:10.1002/jcp.30172.